Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

TeleCareSpot vs VirtualCare2Go

Two GLP-1 desks, one scoreboard. We put TeleCareSpot and VirtualCare2Go head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 27 · Grade B

TeleCareSpot

Visit TeleCareSpot Full brief →
vs
No. 113 · Grade C

VirtualCare2Go

Visit VirtualCare2Go Full brief →

The verdict

TeleCareSpot takes this head-to-head.

TeleCareSpot scores 85 to 72 on our six-factor Brief Score — A nationwide desk with an oral option — full-formulary, but priced at the premium end.

That doesn't make VirtualCare2Go a bad call — it's best for readers who want same-day compounded semaglutide (injection or oral tablet) with nationwide shipping. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
84
48
Supply Reliability
86
69
Transparency
87
88
Access Breadth
87
96
Clinical Oversight
86
72
Track Record
81
68
TeleCareSpotBrief Score 85 · 72VirtualCare2Go

Price, coverage & the tracker

TeleCareSpotVirtualCare2Go
Brief Score85/100 (B)72/100 (C)
Semaglutide$299/moFrom $279/mo (starting dose, compounded)
Tirzepatide$399/moFrom $629/mo (starting dose, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

TeleCareSpot: $299 sema / $399 tirz nationwide, with an oral route.

VirtualCare2Go: New to the tracker on 1 August 2026. The published line reads From $279/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.